Britschgi C - Search Results

1

BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assembly.

Frischknecht L, Britschgi C, Galliker P, Christinat Y, Vichalkovski A, Gstaiger M, Kovacs WJ, Krek W. Frischknecht L, et al. Among authors: britschgi c. Sci Rep. 2019 May 23;9(1):7779. doi: 10.1038/s41598-019-44112-7. Sci Rep. 2019. PMID: 31123282 Free PMC article.

2

ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER Trial.

Soo RA, Dafni U, Han JY, Cho BC, Nadal E, Yeo CM, Carcereny E, de Castro J, Sala MA, Coate L, Provencio M, Britschgi C, Vagenknecht P, Dimopoulou G, Kammler R, Finn SP, Peters S, Stahel RA; ETOP 10-16 BOOSTER Collaborators. Soo RA, et al. Among authors: britschgi c. Clin Cancer Res. 2024 Nov 15;30(22):5180-5191. doi: 10.1158/1078-0432.CCR-24-0932. Clin Cancer Res. 2024. PMID: 39250635 Clinical Trial.

3

Colorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1.

Lipinski KA, Britschgi C, Schrader K, Christinat Y, Frischknecht L, Krek W. Lipinski KA, et al. Among authors: britschgi c. Oncotarget. 2016 May 17;7(20):29635-47. doi: 10.18632/oncotarget.8816. Oncotarget. 2016. PMID: 27105489 Free PMC article.

4

Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer.

Akhoundova D, Pietge H, Hussung S, Kiessling M, Britschgi C, Zoche M, Rechsteiner M, Weber A, Fritsch RM. Akhoundova D, et al. Among authors: britschgi c. JCO Precis Oncol. 2021 Nov;5:1082-1087. doi: 10.1200/PO.21.00107. JCO Precis Oncol. 2021. PMID: 34994629 Free article. No abstract available.

5

Structure-based prediction of BRAF mutation classes using machine-learning approaches.

Krebs FS, Britschgi C, Pradervand S, Achermann R, Tsantoulis P, Haefliger S, Wicki A, Michielin O, Zoete V. Krebs FS, et al. Among authors: britschgi c. Sci Rep. 2022 Jul 22;12(1):12528. doi: 10.1038/s41598-022-16556-x. Sci Rep. 2022. PMID: 35869122 Free PMC article.

6

ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer.

Akhoundova D, Hussung S, Sivakumar S, Töpfer A, Rechsteiner M, Kahraman A, Arnold F, Angst F, Britschgi C, Zoche M, Moch H, Weber A, Sokol E, Fritsch RM. Akhoundova D, et al. Among authors: britschgi c. Int J Cancer. 2022 Dec 15;151(12):2161-2171. doi: 10.1002/ijc.34257. Epub 2022 Aug 30. Int J Cancer. 2022. PMID: 36053834 Free PMC article.

7

Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth.

Uka R, Britschgi C, Krättli A, Matter C, Mihic D, Okoniewski MJ, Gualandi M, Stupp R, Cinelli P, Dummer R, Levesque MP, Shakhova O. Uka R, et al. Among authors: britschgi c. Oncogene. 2020 May;39(20):4132-4154. doi: 10.1038/s41388-020-1267-7. Epub 2020 Apr 1. Oncogene. 2020. PMID: 32238882 Free PMC article.

8

Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer.

Britschgi C, Riesterer O, Burger IA, Guckenberger M, Curioni-Fontecedro A. Britschgi C, et al. Radiat Oncol. 2018 May 31;13(1):102. doi: 10.1186/s13014-018-1049-3. Radiat Oncol. 2018. PMID: 29855323 Free PMC article.

9

Acquired NF2 mutation confers resistance to TRK inhibition in an ex vivo LMNA::NTRK1-rearranged soft-tissue sarcoma cell model.

Chen Y, Steiner S, Hagedorn C, Kollar S, Pliego-Mendieta A, Haberecker M, Plock J, Britschgi C, Planas-Paz L, Pauli C. Chen Y, et al. Among authors: britschgi c. J Pathol. 2024 Jun;263(2):257-269. doi: 10.1002/path.6282. Epub 2024 Apr 12. J Pathol. 2024. PMID: 38613194

10

Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma.

Planas-Paz L, Pliego-Mendieta A, Hagedorn C, Aguilera-Garcia D, Haberecker M, Arnold F, Herzog M, Bankel L, Guggenberger R, Steiner S, Chen Y, Kahraman A, Zoche M, Rubin MA, Moch H, Britschgi C, Pauli C. Planas-Paz L, et al. Among authors: britschgi c. EMBO Mol Med. 2023 Apr 11;15(4):e16863. doi: 10.15252/emmm.202216863. Epub 2023 Feb 13. EMBO Mol Med. 2023. PMID: 36779660 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters